
Kara Renita Mcmillian
Examiner (ID: 13893, Phone: (571)270-5236 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1623, 1627, 1622 |
| Total Applications | 1197 |
| Issued Applications | 307 |
| Pending Applications | 111 |
| Abandoned Applications | 791 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14464541
[patent_doc_number] => 20190183910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS
[patent_app_type] => utility
[patent_app_number] => 16/311969
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311969 | ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS | Jun 20, 2017 | Abandoned |
Array
(
[id] => 19075284
[patent_doc_number] => 11944626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Small molecule inhibitors of ALDH and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/311533
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26643
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311533
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311533 | Small molecule inhibitors of ALDH and uses thereof | Jun 19, 2017 | Issued |
Array
(
[id] => 14563809
[patent_doc_number] => 20190209511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => THERMOSTABLE FORMULATION OF BIOLOGICALLY ACTIVE SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 16/311776
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311776 | Thermostable formulation of biologically active substances | Jun 18, 2017 | Issued |
Array
(
[id] => 14563807
[patent_doc_number] => 20190209510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => SYNERGISTIC EFFECTS, AUGMENTING ANTIMICROBAL EFFECTS OF LIPIDS
[patent_app_type] => utility
[patent_app_number] => 16/311748
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311748 | SYNERGISTIC EFFECTS, AUGMENTING ANTIMICROBAL EFFECTS OF LIPIDS | Jun 18, 2017 | Abandoned |
Array
(
[id] => 14210505
[patent_doc_number] => 20190117637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 16/309733
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309733 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN | Jun 12, 2017 | Abandoned |
Array
(
[id] => 14743761
[patent_doc_number] => 20190255054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHODS AND COMPOSITIONS FOR MANAGING NEUROINFLAMMATION AND NEURODEGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/308003
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308003 | Methods and compositions for managing neuroinflammation and neurodegeneration | Jun 6, 2017 | Issued |
Array
(
[id] => 14743633
[patent_doc_number] => 20190254990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => FOOD OR BEVERAGE COMPOSITION CONTAINING ASTAXANTHIN
[patent_app_type] => utility
[patent_app_number] => 16/308034
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308034 | FOOD OR BEVERAGE COMPOSITION CONTAINING ASTAXANTHIN | Jun 6, 2017 | Abandoned |
Array
(
[id] => 12057078
[patent_doc_number] => 20170333422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'Morphinan Derivatives for the Treatment of Drug Overdose'
[patent_app_type] => utility
[patent_app_number] => 15/613431
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5652
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613431
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613431 | Morphinan Derivatives for the Treatment of Drug Overdose | Jun 4, 2017 | Abandoned |
Array
(
[id] => 18909253
[patent_doc_number] => 11872216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Pharmaceutical formulation comprising cineole and amoxicillin
[patent_app_type] => utility
[patent_app_number] => 16/306262
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 25274
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306262
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306262 | Pharmaceutical formulation comprising cineole and amoxicillin | Jun 1, 2017 | Issued |
Array
(
[id] => 11954764
[patent_doc_number] => 20170258916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Pharmaceutical Composition Containing Sympathomimetic Amine Salt and Co-distillable Additive'
[patent_app_type] => utility
[patent_app_number] => 15/609723
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5825
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609723 | Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive | May 30, 2017 | Issued |
Array
(
[id] => 12621462
[patent_doc_number] => 20180098984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/601150
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601150 | PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | May 21, 2017 | Abandoned |
Array
(
[id] => 14864697
[patent_doc_number] => 20190282590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => MEDICAMENT FOR TREATMENT AND/OR PROPHYLACTIC TREATMENT OF BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 16/300653
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300653 | MEDICAMENT FOR TREATMENT AND/OR PROPHYLACTIC TREATMENT OF BREAST CANCER | May 11, 2017 | Abandoned |
Array
(
[id] => 12117353
[patent_doc_number] => 20180000939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/591818
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16134
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591818 | Low molecular weight cationic lipids for oligonucleotide delivery | May 9, 2017 | Issued |
Array
(
[id] => 14273421
[patent_doc_number] => 20190133995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => METHODS FOR THE TREATMENT OF INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/096550
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096550 | METHODS FOR THE TREATMENT OF INFECTION | Apr 27, 2017 | Abandoned |
Array
(
[id] => 14069101
[patent_doc_number] => 20190083438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => ACETYL-LEUCINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR IMPROVED MOBILITY AND COGNITIVE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/093780
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093780 | Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function | Apr 18, 2017 | Issued |
Array
(
[id] => 14227043
[patent_doc_number] => 20190125694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => METHOD FOR TREATMENT OF VISUAL STRESS CONDITIONS AND COMPOSITIONS USED THEREIN
[patent_app_type] => utility
[patent_app_number] => 16/094017
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094017 | METHOD FOR TREATMENT OF VISUAL STRESS CONDITIONS AND COMPOSITIONS USED THEREIN | Apr 13, 2017 | Abandoned |
Array
(
[id] => 14712559
[patent_doc_number] => 20190247343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/094183
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094183 | USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES | Apr 12, 2017 | Abandoned |
Array
(
[id] => 14338685
[patent_doc_number] => 20190151315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => Drug For Preventing Or Treating Lactic Acidosis
[patent_app_type] => utility
[patent_app_number] => 16/091373
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091373 | Drug For Preventing Or Treating Lactic Acidosis | Apr 6, 2017 | Abandoned |
Array
(
[id] => 14099387
[patent_doc_number] => 20190091369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => COLLAGEN-BASED DEVICE HAVING ANTIFUNGAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/091761
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091761 | COLLAGEN-BASED DEVICE HAVING ANTIFUNGAL PROPERTIES | Apr 5, 2017 | Abandoned |
Array
(
[id] => 14336929
[patent_doc_number] => 20190150437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => USE OF SESQUITERPENES AND THEIR ANALOGS AS GREEN INSECTICIDES FOR CONTROLLING DISEASE VECTORS AND PLANT PESTS
[patent_app_type] => utility
[patent_app_number] => 16/091696
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091696 | USE OF SESQUITERPENES AND THEIR ANALOGS AS GREEN INSECTICIDES FOR CONTROLLING DISEASE VECTORS AND PLANT PESTS | Apr 5, 2017 | Abandoned |